Join your colleagues in Sydney, Australia, for the 2024 Highlights of ASH® in Asia-Pacific on February 16 – 17, 2024. International hematologists will present an unbiased expert analysis of
the most influential research presented at the 2023 ASH Annual Meeting as well as discuss the breakthroughs that will influence the Asia-Pacific region the most.
By participating in this meeting, you will be able to:
 Examine advances in clinical and translational hematologic research most relevant to the region
 Recap standout abstracts from the 65th ASH Annual Meeting
 Discuss new patient management and care strategies, specific to your region, with leading faculty in the field
 Improve your therapeutic and overall practice methods
Join in the following activities:
 Interactive panel discussions about the standout abstracts presented at the 2023 ASH Annual Meeting
 Lunch with the Experts Session: An opportunity to discuss relevant topics and case studies in a setting that fosters interaction with program speakers.
 The latest on CAR T-cell therapy, hematopoietic stem cell transplantation, and more.

 Countless networking opportunities in small groups with no competing sessions.

Registration is available at https://www.hematology.org/meetings/highlights/asia. ASH is proud to co-host this meeting with the Haematology Society of Australia and New Zealand.

Session Information

For the most up to date information about sessions, schedules, and speakers, please visit https://www.hematology.org/meetings/highlights/asia.

Details below are accurate as of Oct. 25, 2023.

Friday, February 16

8:00 a.m.        

Registration and Exhibition Opens

8:45 a.m.        

Welcome and Introductions

9:00 a.m.        

Clonal Hematopoiesis and Myelodysplastic Syndromes

Radhika Gangaraju, MD, University of Alabama at Birmingham

9:30 a.m.        

Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia

David Ross, PhD, Flinders Medical Centre

10:00 a.m.      

Panel Discussion

10:30 a.m.      

Coffee Break and Exhibition

11:00 a.m.      

Autoimmunity and Complement Disorders

Shruti Chaturvedi, MBBS, Johns Hopkins University

11:30 a.m.      

Inherited Bleeding Disorders

Tyler Buckner, MD, MSc, University of Colorado Denver

12:00 p.m.     

Panel Discussion

12:30 p.m.     

Lunch with the Experts Session

1:30 p.m.        

Special Education Session: Hematology in Special Groups

TBD

2:30 p.m.        

Nosocomial Hematological Complications

Lana Castellucci, MD, MSc, University of Ottawa

3:00 p.m.        

Panel Discussion

3:30 p.m.        

Coffee Break and Exhibition

4:00 p.m.        
Diagnosis, Management, and Treatment of VTE

Neil Zakai, MD, University of Vermont

4:30 p.m.        
Hemoglobinopathies

TBD

5:00 p.m.        
Panel Discussion

5:30 p.m.        
Highlights of ASH Day 1 Program Adjournment

Saturday, February 17

8:00 a.m.        

Registration and Exhibition

8:45 a.m.        

Welcome and Introductions 

9:00 a.m.        

Transfusion Medicine: Blood Banking and Apheresis

Erica Wood, AO, Monash University

9:30 a.m.        

Hematopoietic Stem Cell Transplantation

John Magenau, MD, Monash University

10:00 a.m.      

Panel Discussion

10:30 a.m.      
Coffee Break and Exhibition

11:00 a.m.      
Special Education Session: CAR T- Cell Therapy

Matthew Frank, MD, Stanford University

Loretta Nastoupil, MD, MD Anderson Cancer Center

Robin Sanderson, PhD, King’s College London

12:30 p.m.     

Lunch with the Experts Session

1:30 p.m.        

High-Grade Lymphoma (Including CAR T-cell Therapy)

TBD

2:00 p.m.        

Low-Grade Lymphoma

(Including Chronic Lymphoid Leukemia)

Adam Kittai, MD, Ohio State University

2:30 p.m.        

Panel Discussion

3:00 p.m.        

Coffee Break and Exhibition

3:30 p.m.        

Acute Lymphoblastic Leukemia

William Stevenson, PhD, Royal North Shore Hospital

4:00 p.m.        

Acute Myeloid Leukemia

Andrew Wei, PhD, Peter Maccallum Cancer Centre

4:30 p.m.        

Myeloma & Plasma Cell Dyscrasia

P. Joy Ho, MBBS, University of Sydney

5:00 p.m.        

Panel Discussion

5:30 p.m.

Meeting Adjournment

Last Updated on 20/12/2023 by Dr. Khaza Amirul Islam